Skip to content
Latest News
ContraFect, CFRX, Down 76% On Drug Trial Failure – What Happens Now?

Key points: ContraFect's MRSE drug trial failed the futility test But the key question is what else is in the pipeline? Is there anything else potentially of value?

Tim Worstall
Tim Worstall
Eqtec Share Price Plunged 27.7% After Raising £3.75M. Is It a Buy?

Key points: The Eqtec share price plunged 27.7% after completing a fundraising event. However, the company raised £3.75m after selling new shares a

Simon Mugo
IAG And Heathrow, Wizz And Doncaster – Who Will Win, Airlines Or Airports?

Key points: IAG and Wizz are both having fights with airports Heathrow is limiting IAG and Wizz leaving Doncaster Airlines and airports are in conflict over streams of r

Tim Worstall
Tim Worstall
MGC Pharmaceuticals (MXC) Shares Surged 47.4% Today. Here’s Why?

Key points: MGC Pharmaceuticals’ share price surged 47%+ on clinical trial results. The bio-pharma company reported positive ArtemiC Support®

Simon Mugo
Sabre Insurance Down 27% On Results – How Bad Could This Get?

Key points: Sabre Insurance is down 27% on interim results for the half year Inflation on claims bills is harming the underwriting performance This could revert, as Sabr

Tim Worstall
Tim Worstall
XORTX Therapeutics (XRTX) Stock Soared 82%+ Today. Here’s Why.

Key points: The XORTX Therapeutics (XRTX) stock soared 82.7% today. Investors reacted positively to positive initial topline results.

Simon Mugo
Norwegian (NCLH) Stock Price Is Down 47.1% YTD. Has It Bottomed?

Key points: The Norwegian (NCLH) stock price has fallen 47.1% in 2022. However, the cruise ship stock seems to have recently bottomed.

Simon Mugo
The Ironsource Stock Price Surged 54%+ on the Merger With Unity Games

Key points: The Ironsource stock price surged 54%+ on the merger with Unity Games. The transaction has attracted positive comments from game develo

Simon Mugo
Why Hemogenyx (HEMO) Share Price Was Unmoved on New R&D Facility

Key points: The Hemogenyx share price remained stuck despite moving into a new building. Investors were unimpressed by the announcement since it wa

Simon Mugo
Further Institutional Involvement in the Decentralized Finance World

Key points: The US Treasury Asks For Public Views On Cryptocurrencies Bank Of England Governor Urges Crypto Regulation A Recent Stream Of Institutional Involvement In The

Steve Miley
Humanigen Down 57% Premarket – The Covid Drug Doesn’t Work Apparently?

Key points: Humanigen's covid drug appears no better than a placebo This reverse the stock's climb in anticipation of better results The drug might still find other uses w

Tim Worstall
Tim Worstall
TDH Holdings Down 98% From Peak, Up 35% Premarket – What’s Happening Here?

Key points: TDH Holdings is down 98% from peak and up 35% premarket The trigger seems to be the withdrawal of a filing to sell stock The actual implication might not be

Tim Worstall
Tim Worstall
Why Horizonte Minerals (HZM) Shares Barely Moved On Contract Awards

Key points: The Horizonte Minerals (HZM) shares barely moved on contract awards. Investors ignored the news despite its significance to the Araguaia

Simon Mugo
Ironveld Down 10% On Placing News – Will The Share Price Recover?

Key points: Ironveld has come back to market with a capital raising placing This is to finance the purchase of the second hand smelter What matters is how that capital -

Tim Worstall
Tim Worstall
Powerhouse (PHE) Share Price Has Risen 25.6% in 5 Days. Is It a Buy?

Key points: The Powerhouse Energy share price has risen 25.6% in 5 days. The company today unveiled a new JV agreement with HUI.

Simon Mugo
The Mode Share Price Edged Lower on a £2M Fundraise. What’s Next?

Key points: The Mode share price edged 5.12% lower on a £2m fundraise. The fintech company has witnessed significant changes in its C-suite.

Simon Mugo
Ilika, IKA, Drops 9% On Final Results – What’s Next Here?

Key points: Ilika's down another 9% on final results Not a great change from the earlier trading announcement Just that no solution has yet been found to the earlier sit

Tim Worstall
Tim Worstall
The Rivian (RIVN) Stock Price Has Fallen 71.5% in 2022. Can It Recover?

Key points: The Rivian stock price has fallen 71.5% in 2022 and could be headed lower. The decline has been driven by multiple factors led by suppl

Simon Mugo
Peloton Stock Price Edges Higher on the Decision to Offshore Production

Key points: The Peloton stock price edged higher on decisions to offshore production. Investors seemed okay with the move, which could have a deepe

Simon Mugo
The Canoo (GEOV) Stock Price Soared 94% on Walmart Deal. Is It a Buy?

Key points: The Canoo (GOEV) stock rice soared 94% premarket on the Walmart deal. Investors reacted positively to the deal to deliver 4,500 EVs to

Simon Mugo
Analysis Stocks Markets Strategies